eRAM
encyclopedia of Rare Disease Annotation for Precision Medicine
| Disease | small cell carcinoma |
| Comorbidity | C0007131|nsclc |
| Sentences | 7 |
| PubMedID- 21595568 | Context: nonsmall cell lung cancers with neuroendocrine differentiation (nsclc-nd) may demonstrate biologic behavior intermediate between nsclc and small cell lung cancer (sclc) with impact on prognosis. |
| PubMedID- 23077446 | Found significantly lower adc values for sclc when comparing with nsclc groups in a similar patient population.26 liu et al. |
| PubMedID- 23420619 | There are few treatment options in second-line chemotherapy for sclc treatment compared with nsclc treatment, and further biological research of sclc is required to identify pathways that may be targeted with new antitumor drugs. |
| PubMedID- 22700587 | In contrast, retinoic acid receptor-γ, thyroid hormone receptor-β and vitamin d receptor (vdr) showed moderately or dramatically reduced expression in sclc compared with the nsclc or hbec (fig. |
| PubMedID- 20624269 | These results support the hypothesis that differential expression of mirnas could contribute to the differentiation of lung cancer cells from one subtype to another, in which sclc could result from nsclc cells by gradually acquiring sclc properties through the cumulative dysregulation of mirnas, and that manipulating the levels of specific mirnas levels might prevent the differentiation of lung cancer cells toward a more malignant phenotype. |
| PubMedID- 24204697 | Similarly, in contrast to nsclc, growth of small cell lung cancer cells (sclc) is driven through the establishment of neuropeptide autocrine loops [43]. |
| PubMedID- 23244181 | It is classified into non-small cell lung cancer (nsclc) representing 70-80% of cases and small cell lung cancer (sclc) which has neuroendocrine properties with poor outcome. |
Page: 1